Ultralong-acting sulphonamide (Fanasil).
D003692:Delayed-Action Preparations / Q000009:adverse effects; D006801:Humans; D011014:Pneumonia / Q000517:prevention & control; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced*; D013449:Sulfonamides / Q000009:adverse effects* / Q000627:therapeutic use
D003692:Delayed-Action Preparations; D013449:Sulfonamides